Created in 2012 (United States), IMLINIR own
126 sister brands
and 17477 competing brands.
IMLINIR is owned by Celgene, listed on the stock exchange of New York
The sector of IMLINIR is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.